BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11075590)

  • 1. [A case of Crohn's disease that shows the improvement of the gastric disorder by the administration of mesalazine powder].
    Nagamata H; Torii A; Izumi M; Anami M; Yamashita N; Inadama E; Toda G
    Nihon Shokakibyo Gakkai Zasshi; 2000 Oct; 97(10):1261-6. PubMed ID: 11075590
    [No Abstract]   [Full Text] [Related]  

  • 2. A rare case of gastric Crohn's disease associated with immune thrombocytopenic purpura.
    Shaaban H; Maroules M
    J Crohns Colitis; 2013 Oct; 7(9):e401-2. PubMed ID: 23608308
    [No Abstract]   [Full Text] [Related]  

  • 3. Education and imaging. Gastrointestinal: gastric Crohn's disease.
    Tseng TC; Chang YT; Wong JM
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1690. PubMed ID: 17845696
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesalazine as a maintenance treatment in Crohn's disease.
    Sutherland LR; Steinhart AH
    Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of successful mesalazine enema for rectal cavitating ulcer of Crohn's disease].
    Kosaka T; Tanaka J; Tomita T; Matsumura T; Ohnishi K; Fukuda Y; Tamura K; Shimoyama T
    Nihon Shokakibyo Gakkai Zasshi; 2001 Jun; 98(6):650-4. PubMed ID: 11436282
    [No Abstract]   [Full Text] [Related]  

  • 6. [Angioedema in Crohn's disease possibly due to mesalazine].
    Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
    Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
    [No Abstract]   [Full Text] [Related]  

  • 7. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
    Rutgeerts P
    Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesalazine-induced Churg-Strauss syndrome in a patient with Crohn's disease and sclerosing cholangitis.
    Sinico RA; Sabadini E; Maresca AM
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S104. PubMed ID: 16859609
    [No Abstract]   [Full Text] [Related]  

  • 9. Obstructing Crohn's disease of the duodenum: is surgery always mandatory?
    Karaoglu AO; Yukselen V
    Int J Clin Pract; 2004 Feb; 58(2):221-3. PubMed ID: 15055874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesalamine in the treatment of active Crohn's disease.
    Dignass A; Marteau P
    Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesalamine maintenance therapy for Crohn's disease.
    Feagan BG; McDonald JW
    Gastroenterology; 2001 Feb; 120(2):585-6. PubMed ID: 11271451
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB; Klemt-Kropp M
    Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalamine and relapse prevention in Crohn's disease.
    Cottone M; Cammà C
    Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
    Clemett D; Markham A
    Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E;
    Am J Gastroenterol; 2002 Mar; 97(3):649-53. PubMed ID: 11922560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mesalazine is effective in Crohn disease].
    Quartarolo JP
    Ugeskr Laeger; 2005 Apr; 167(16):1767. PubMed ID: 15898611
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.
    Akobeng AK
    Am J Gastroenterol; 2011 Oct; 106(10):1857; author reply 1857-8. PubMed ID: 21979212
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE; Hanauer SB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case against using 5-aminosalicyclates in Crohn's disease: con.
    Stange EF
    Inflamm Bowel Dis; 2005 Jun; 11(6):613-5. PubMed ID: 15905711
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn's disease.
    Faller M; Gasser B; Massard G; Pauli G; Quoix E
    Respiration; 2000; 67(4):459-63. PubMed ID: 10940806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.